Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients Supplements
1 other identifier
interventional
2,601
1 country
3
Brief Summary
In collaboration with the Federal Government of Nigeria and Bauchi State, Nutrition International (NI) conducted a three-year implementation research study to assess whether adherence solutions - developed through a human-centered designed (HCD) approach - could improve adherence to multiple micronutrient supplementation (MMS) among pregnant women in Nigeria. These set of adherence solutions focused on strengthening the capacity of healthcare workers and community members, improving nutrition counselling within antenatal care, and engaging pregnant women' family members to support consistent MMS intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2024
CompletedFirst Submitted
Initial submission to the registry
January 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2025
CompletedFirst Posted
Study publicly available on registry
June 12, 2026
CompletedJune 12, 2026
June 1, 2026
1.2 years
January 14, 2025
June 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to MMS
Defined as "when pregnant women consume the right dose of multiple micronutrient supplementation (MMS) at the right time throughout pregnancy". Measured through self-reported daily consumption, self-reported average consumption rate over a three-month period, and pill count.
At baseline and approximately 2 years after (endline)
Secondary Outcomes (1)
Acceptability
At baseline and approximately 2 years after (endline)
Study Arms (2)
Control arm
NO INTERVENTIONIntervention Arm
EXPERIMENTALEligible pregnant women received implementation approaches
Interventions
Implementation approaches are human-centered designed strategies aimed at optimizing pregnant women's daily adherence to MMS.
Eligibility Criteria
You may qualify if:
- Pregnant/post-partum women
- Women of reproductive age (15-49 years of age)
- Pregnant or up to 3 months post-partum women
- Having reportedly received at least one MMS bottle at least 30 days before start of data collection from a participating public health facility-
- Provide consent for participation
- Health Care Workers (HCWs)
- HCWs providing ANC services including MMS and IFAs to pregnant women at the selected health facilities
- Husbands
- Husbands of the enrolled pregnant women At endline, the same criteria apply.
You may not qualify if:
- Anemic pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Public health facilities in Dass
Dass, Bauchi, Nigeria
Public health facilities in Ganjuwa
Ganjuwa, Bauchi, Nigeria
Public health facilities in Giade
Giade, Bauchi, Nigeria
Study Officials
- PRINCIPAL INVESTIGATOR
Babajide Adebisi
Nutrition International
- PRINCIPAL INVESTIGATOR
Jennifer Busch Hallen
Nutrition International
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2025
First Posted
June 12, 2026
Study Start
March 7, 2024
Primary Completion
May 26, 2025
Study Completion
May 26, 2025
Last Updated
June 12, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- May 2026 for 3 years.
- Access Criteria
- Access to the data will be restricted to the data collectors and study team, both of whom will sign a confidentiality agreement. When transmitting this data to investigators approved for this study, anonymized datasets will then be sent by encrypted zipped file in Stata format, The password to access these files will be communicated separately using email. The encryption keys will be transferred in the same way to co-investigators, if and as needed.
Published IPD will be shared upon reasonable request